Kathryn King - Aptinyx VP Operations

APTXDelisted Stock  USD 0.07  0.01  16.67%   

Insider

Kathryn King is VP Operations of Aptinyx
Phone847 871 0377
Webhttps://www.aptinyx.com

Aptinyx Management Efficiency

The company has return on total asset (ROA) of (0.5135) % which means that it has lost $0.5135 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3806) %, meaning that it created substantial loss on money invested by shareholders. Aptinyx's management efficiency ratios could be used to measure how well Aptinyx manages its routine affairs as well as how well it operates its assets and liabilities.
Aptinyx currently holds 22.11 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Aptinyx has a current ratio of 15.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Aptinyx's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

MBA MDSpero Therapeutics
43
Jason DavisVirax Biolabs Group
52
Professor MDAllarity Therapeutics
67
Thomas CPAAditxt Inc
51
Xiaoqin MDAvenue Therapeutics
49
Christopher OgdenCytomX Therapeutics
40
Satyavrat CFASpero Therapeutics
51
Catherine FratilaAdial Pharmaceuticals
N/A
Qiyong LiuTranscode Therapeutics
60
Uri MDAssembly Biosciences
52
David JinAvenue Therapeutics
34
Dr IVAssembly Biosciences
52
Michele AndersonAssembly Biosciences
N/A
Robert DudleyTranscode Therapeutics
73
MD DrScAllarity Therapeutics
81
Amro AlbannaAditxt Inc
54
Sergio QuezadaAchilles Therapeutics PLC
49
James FosterVirax Biolabs Group
39
DPHIL DPhilCytomX Therapeutics
57
Karl MDAchilles Therapeutics PLC
57
Narayan PrabhuReviva Pharmaceuticals Holdings
52
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. Aptinyx (APTX) is traded on NASDAQ Exchange in USA and employs 12 people.

Management Performance

Aptinyx Leadership Team

Elected by the shareholders, the Aptinyx's board of directors comprises two types of representatives: Aptinyx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptinyx. The board's role is to monitor Aptinyx's management team and ensure that shareholders' interests are well served. Aptinyx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptinyx's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kathryn King, VP Operations
Norbert Riedel, President CEO, Director
Patrick Flavin, Sr Relations
Molly Dir, VP HR
Ashish Khanna, Chief Business Officer
Harald MD, VP Affairs
Tim Noffke, VP Staff
MD BCh, Pres CEO

Aptinyx Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aptinyx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in Aptinyx Stock

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio